BlackRock Inc. - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 32 filers reported holding NRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$75,586
-46.2%
290,7140.0%0.00%
Q2 2023$140,560
-43.2%
290,714
-22.5%
0.00%
Q1 2023$247,325
-40.2%
375,247
+0.7%
0.00%
Q4 2022$413,507
-13.9%
372,529
-42.6%
0.00%
Q3 2022$480,000
+22.8%
648,538
-0.6%
0.00%
Q2 2022$391,000
-69.6%
652,315
+24.1%
0.00%
Q1 2022$1,287,000
-47.8%
525,493
+1.9%
0.00%
Q4 2021$2,464,000515,4480.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders